104 related articles for article (PubMed ID: 11323277)
1. Self-peptide anaphylaxis.
Marshall H
Trends Immunol; 2001 May; 22(5):242. PubMed ID: 11323277
[No Abstract] [Full Text] [Related]
2. Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis.
Glabinski AR; Tani M; Tuohy VK; Ransohoff RM
Methods Enzymol; 1997; 288():182-90. PubMed ID: 9356995
[No Abstract] [Full Text] [Related]
3. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide.
Pedotti R; Mitchell D; Wedemeyer J; Karpuj M; Chabas D; Hattab EM; Tsai M; Galli SJ; Steinman L
Nat Immunol; 2001 Mar; 2(3):216-22. PubMed ID: 11224520
[TBL] [Abstract][Full Text] [Related]
4. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Wegmann KW; Archie Bouwer HG; Whitham RH; Hinrichs DJ
J Neuroimmunol; 2014 Sep; 274(1-2):46-52. PubMed ID: 24997489
[TBL] [Abstract][Full Text] [Related]
5. Suppression of autoimmunity via microbial mimics of altered peptide ligands.
Steinman L; Utz PJ; Robinson WH
Curr Top Microbiol Immunol; 2005; 296():55-63. PubMed ID: 16323420
[TBL] [Abstract][Full Text] [Related]
6. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
Greer JM; Pender MP
J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
[TBL] [Abstract][Full Text] [Related]
7. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
Mohindru M; Kang B; Kim BS
J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
[TBL] [Abstract][Full Text] [Related]
9. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
[TBL] [Abstract][Full Text] [Related]
10. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
11. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
[TBL] [Abstract][Full Text] [Related]
12. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
13. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1.
Aharoni R; Teitelbaum D; Sela M; Arnon R
J Neuroimmunol; 1998 Nov; 91(1-2):135-46. PubMed ID: 9846830
[TBL] [Abstract][Full Text] [Related]
14. Active immunization with proteolipid protein (190-209) induces ascending paralysing experimental autoimmune encephalomyelitis in C3H/HeJ mice.
Göbel K; Bittner S; Ruck T; Budde T; Wischmeyer E; Döring F; Wiendl H; Meuth SG
J Immunol Methods; 2011 Mar; 367(1-2):27-32. PubMed ID: 21199659
[TBL] [Abstract][Full Text] [Related]
15. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
Massilamany C; Steffen D; Reddy J
J Neuroimmunol; 2010 Feb; 219(1-2):17-24. PubMed ID: 20005578
[TBL] [Abstract][Full Text] [Related]
16. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
[TBL] [Abstract][Full Text] [Related]
17. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
[TBL] [Abstract][Full Text] [Related]
19. Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Recks MS; Grether NB; van der Broeck F; Ganscher A; Wagner N; Henke E; Ergün S; Schroeter M; Kuerten S
Clin Immunol; 2015 Jul; 159(1):93-106. PubMed ID: 25959684
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.
Gerdoni E; Gallo B; Casazza S; Musio S; Bonanni I; Pedemonte E; Mantegazza R; Frassoni F; Mancardi G; Pedotti R; Uccelli A
Ann Neurol; 2007 Mar; 61(3):219-27. PubMed ID: 17387730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
